☰

Kelly A. Hogan, Ph.D. - Publications

Affiliations: 
2001 University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Role of Fibrinogen in Cardiovascular Diseases
Tree Info Similar researchers PubMed Report error

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2004 Hogan KA, Merenbloom BK, Kim HS, Lord ST. Neonatal bleeding and decreased plasma fibrinogen levels in mice modeled after the dysfibrinogen Vlissingen/Frankfurt IV. Journal of Thrombosis and Haemostasis : Jth. 2: 1484-7. PMID 15304068 DOI: 10.1111/J.1538-7836.2004.00841.X  0.523
2003 Terasawa F, Hogan KA, Kani S, Hirose M, Eguchi Y, Noda Y, Hongo M, Okumura N. Fibrinogen Otsu I:A gammaAsn319,Asp320 deletion dysfibrinogen identified in an asymptomatic pregnant woman. Thrombosis and Haemostasis. 90: 757-8. PMID 14515199 DOI: 10.1160/Th03-04-0201  0.31
2002 Remijn JA, IJsseldijk MJ, van Hemel BM, Galanakis DK, Hogan KA, Lounes KC, Lord ST, Sixma JJ, de Groot PG. Reduced platelet adhesion in flowing blood to fibrinogen by alterations in segment gamma316-322, part of the fibrin-specific region. British Journal of Haematology. 117: 650-7. PMID 12028038 DOI: 10.1046/J.1365-2141.2002.03467.X  0.585
2002 Hogan KA, Weiler H, Lord ST. Mouse models in coagulation. Thrombosis and Haemostasis. 87: 563-74. PMID 12008936 DOI: 10.1055/S-0037-1613050  0.553
2001 Remijn JA, Lounes KC, Hogan KA, Lord ST, Galanakis DK, Sixma JJ, De Groot PG. Mutations on fibrinogen (gamma 316-322) are associated with reduction in platelet adhesion under flow conditions. Annals of the New York Academy of Sciences. 936: 444-8. PMID 11460499 DOI: 10.1111/J.1749-6632.2001.Tb03528.X  0.572
2001 Hogan KA, Bolliger B, Okumura N, Lord ST. The formation of beta fibrin requires a functional a site. Annals of the New York Academy of Sciences. 936: 219-22. PMID 11460478 DOI: 10.1111/J.1749-6632.2001.Tb03509.X  0.508
2001 Lounes KC, Okumura N, Hogan KA, Ping L, Lord ST. Polymerization site a function dependence on structural integrity of its nearby calcium binding site. Annals of the New York Academy of Sciences. 936: 205-9. PMID 11460475 DOI: 10.1111/J.1749-6632.2001.Tb03506.X  0.512
2001 Hogan KA, Maeda N, Kluckman KD, Lord ST. Synthesis of a mouse model of the dysfibrinogen Vlissingen/Frankfurt IV. Annals of the New York Academy of Sciences. 936: 117-21. PMID 11460467 DOI: 10.1111/J.1749-6632.2001.Tb03498.X  0.548
2000 Hogan KA, Lord ST, Okumura N, Terasawa F, Galanakis DK, Scharrer I, Gorkun OV. A functional assay suggests that heterodimers exist in two C-terminal gamma-chain dysfibrinogens: Matsumoto I and Vlissingen/Frankfurt IV. Thrombosis and Haemostasis. 83: 592-7. PMID 10780323  0.566
2000 Hogan KA, Gorkun OV, Lounes KC, Coates AI, Weisel JW, Hantgan RR, Lord ST. Recombinant fibrinogen Vlissingen/Frankfurt IV. The deletion of residues 319 and 320 from the gamma chain of firbinogen alters calcium binding, fibrin polymerization, cross-linking, and platelet aggregation. The Journal of Biological Chemistry. 275: 17778-85. PMID 10748039 DOI: 10.1074/jbc.M001618200  0.557
2000 Hogan KA, Lord ST, Okumura N, Terasawa F, Galanakis DK, Scharrer I, Gorkun OV. A Functional Assay Suggests that Heterodimers Exist in Two C-Terminal γ-Chain Dysfibrinogens: Matsumoto I and Vlissingen/Frankfurt IV Thrombosis and Haemostasis. 83: 592-597. DOI: 10.1055/S-0037-1613869  0.58
Show low-probability matches.